Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. - Wikidata - awgldk - TriplyDB

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

http://www.wikidata.org/entity/Q48352448

about

Probing GABA receptor function in schizophrenia with iomazenil The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction Molecular substrates of schizophrenia: homeostatic signaling to connectivity Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal Biological markers and schizophrenia.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis.Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].Linking nucleus accumbens dopamine and blood oxygenation.Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization.[Use of PET and SPECT in psychiatry].Translational studies of alcoholism: bridging the gap.Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes.The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.What is inherited in the predisposition toward alcoholism? A proposed model.Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.Frontal white matter and cingulum diffusion tensor imaging deficits in alcoholism.Developing therapeutics for schizophrenia and other psychotic disorders.Alcohol and the human brain: a systematic review of different neuroimaging methods.Striatal dopamine release in schizophrenia comorbid with substance dependence.New perspectives on schizotypal personality disorder.Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.A pathophysiological framework of hippocampal dysfunction in ageing and disease Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.The role of dopamine for the pathophysiology of schizophrenia.Cannabis, the mind and society: the hash realities.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.Neuroreceptor imaging in psychiatric disorders.Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.

P2860

Q24601700-2D138767-00EB-4E08-9BB2-CE7E0F65AE7F Q28210979-DE984891-4215-414B-83C5-700F051FEAF4 Q28567004-049EAFE3-3BF9-4122-8A26-FEAF6320E6A2 Q28569752-780551DC-1AE4-405C-95CB-2BAEDE655517 Q28590145-9AAEBA31-C723-4F98-A350-A8FF5FA05C28 Q30383611-2C186912-4A8B-4A72-BB69-108DE982C732 Q30416848-04809A31-3BCC-4F8C-BC2D-ECD18F984110 Q30610454-5AC35DA7-14D0-497F-BC9A-F536B2E2193D Q30621233-7D0B8B31-7AA9-48CB-8822-2E82402B8D60 Q30685335-2C766082-F772-44EB-B5DB-D0B6026A6F69 Q30760647-F7207349-67DD-4507-A513-514D360D8887 Q31031649-F2297260-0505-4839-81BA-2A6F436C04AC Q31071498-8D1D20BD-3AE1-4882-9B14-D6381EEFFF33 Q31097702-BE6A7334-9065-4A7E-87BA-C0706877420D Q31116328-706849DF-A9FF-4654-A0E0-A2C799496FCA Q33277865-8A1FFC2F-41D6-42B7-88E9-295864192A5A Q33523307-4E1701C8-A7EE-49C2-B525-30FA63C7838B Q33559892-44989BFC-729E-47CE-B148-C71D34D435B7 Q33623594-1AC83667-C767-46F9-8E02-D9BDF8753D36 Q33623736-5D6FD2CF-6D51-4F1B-9EA3-B92F295C4124 Q33647525-E1034CB3-6086-477C-A9FF-F6117CF73CFD Q33709565-2EEFEBD6-7C8E-4C06-9892-066348F538C3 Q33833648-40875C34-6743-4E98-A0CE-F4737C036CF7 Q33867444-930584B1-2E19-4E88-9302-A275A0CF0F90 Q33894434-1D56201D-4815-4C64-989F-CF940BF6B285 Q33927477-BD23BEA2-20AE-40C8-B7FF-DB736B32601E Q33946985-620FDB49-2866-4953-BE42-67EC27E6E8C6 Q33967245-4A6B50BD-472A-46AC-97A5-04D8D7FD963C Q34028727-831A5363-3447-45E8-8C2D-574AA10C0F2D Q34108295-03EEE991-DFBD-4ACD-8246-154E540982CA Q34159762-E39CF0A0-64E6-4773-B0C3-32D2A6DA455E Q34214060-30956943-2840-4C4B-A455-45F0E1780487 Q34651191-2B9970FC-F1C4-42B7-92D1-51637D51B0FE Q34658860-4E27467A-C48F-434A-BDB1-2F02D9CEB2F1 Q34699888-D80AFFAC-8F1E-4F82-8B5E-712AB3EE9713 Q34703195-8354ABDB-7B61-49B9-91BE-84B8E8F5495B Q34809762-CADB995D-25F0-47A8-BFB0-A5C98A84E7A7 Q35013372-B717377F-D21D-4505-873C-5EA9EB3F0166 Q35037212-C4CE2C28-0298-47BA-9B04-10E9C9C93AE5 Q35071909-33E8BD99-301E-415B-A137-247CA69D9A68

P2860

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

http://www.wikidata.org/entity/Q48352448

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@en

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@nl

type

label

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@en

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@nl

prefLabel

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@en

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@nl

P1433

Q48352448-2AF79A3F-0ADD-4886-8E2F-A033EAD20992

P1476

Q48352448-7B81502F-675D-481E-8434-041209278CF3

P2093

Q48352448-2F0995F9-DA26-415B-923C-C2E43F7806B2

Q48352448-33912BA4-F03C-4ABC-8B2C-144B7CCAAE71

Q48352448-5C9579B3-2989-4C14-8149-D8E453C7251F

Q48352448-6C67FC5F-DA14-496E-BE5F-B9A623054E30

Q48352448-89B63855-4622-41BA-9E7D-A892DA26E85E

Q48352448-8B6EC4F0-BDD1-4BEC-A058-C1675699E210

Q48352448-8F49E5A2-C17B-459F-BA94-8D1CC303A3DE

Q48352448-923FC9D7-FEA1-4BAD-99EB-C405097B5B0C

Q48352448-95D66503-F408-4572-952E-00B3C5F72248

Q48352448-A9222859-AB9F-4001-92DD-46473DC4A4F0

P304

Q48352448-2E443F8F-96C9-42F6-8CA0-7AF9DE59AB69

P31

Q48352448-208513E3-E648-4FE3-B4AF-9AD50525F081

P356

Q48352448-C9808E0A-8DF3-4423-8294-5BA2AB81D436

P407

Q48352448-196E3E03-3ACF-46F1-8E8E-32E4AC71A5F7

P433

Q48352448-5D4CB4B4-16BF-4437-B37B-FE33F1D2994D

P478

Q48352448-3DBFD04D-040C-4DC1-8048-40F70A9BEF6C

P577

Q48352448-01004359-C042-42F0-9C3A-29FBDFF4B59B

P698

Q48352448-DD3764E0-7FE6-47B3-8C9B-E62125C08C0A

P356

AJP.155.11.1550

P1433

American Journal of Psychiatry

P1476

Alterations of benzodiazepine ...... ith SPECT and [123I]iomazenil.

@en

P2093

Abi-Dargham A

http://www.w3.org/2001/XMLSchema#string

Anjilvel S

http://www.w3.org/2001/XMLSchema#string

Baldwin RM

http://www.w3.org/2001/XMLSchema#string

Charney DS

http://www.w3.org/2001/XMLSchema#string

Ellis S

http://www.w3.org/2001/XMLSchema#string

Innis RB

http://www.w3.org/2001/XMLSchema#string

Krystal JH

http://www.w3.org/2001/XMLSchema#string

Laruelle M

http://www.w3.org/2001/XMLSchema#string

Petrakis IL

http://www.w3.org/2001/XMLSchema#string

Rajeevan N

http://www.w3.org/2001/XMLSchema#string

P304

1550-1555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/AJP.155.11.1550

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9812116

http://www.w3.org/2001/XMLSchema#string